CSIMarket
 


Quidel Corporation  (QDEL)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Quidel's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


Return On Equity (Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
(Jun 30 2020)
II. Quarter
Y / Y Equity Change 130.68 % 146.15 % 138.06 % 58.99 % -
Y / Y Net Income Change -71.81 % 342.59 % 1435.07 % 1335.44 % 5226.93 %
Net Income (TTM) in Millions 900 948 810 371 155
Return On Equity (TTM) 70.79 % 88.54 % 95.36 % 56.48 % 26.78 %
Total Ranking # 179 # 109 # 86 # 135 # 349
Equity (TTM) in Millions 1,411 1,490 1,333 849 612
Seq. Equity Change -5.28 % 11.78 % 56.93 % 38.83 % 1.08 %
Seq. Net Income Change -89.29 % -62.12 % 102.41 % 243.33 % 68.13 %


Roe Comment
Quidel Corporation returned in II. Quarter 70.79 % on shareholder's equity, and it was higher than Quidel average return on equity.

ROE decreased compare to previous quarter, due to detoriation of net income.

Within Healthcare sector 24 other companies have achieved higher return on equity. While Return on equity total ranking has deteriorated compare to previous quarter from 109 to 179.

What is ROE?
Return On Equity Company Ranking
Within: No.
Industry # 6
Sector # 25
Overall # 179

Return On Equity Statistics
High Average Low
95.36 %
27.23 %
0.6 %
(Dec 31 2020)   (Sep. 30, 2015)


Annual Return On Equity (Dec 31 2020)
2020
(Dec 31 2019)
2019
(Dec 31 2018)
2018
(Dec 31 2017)
2017
(Dec 31 2016)
2016
Total Equity in Millions 1,333 560 426 227 201
Y / Y Equity Change 138.06 % 31.54 % 87.4 % 13.2 % -8.25 %
Net Income in Millions 810 73 74 -8 -14
Y / Y Net Income Change 1011.18 % -1.7 % - - -
Return On Equity 60.8 % 13.03 % 17.43 % - -





Annual Roe Comment
In 2020 ROE improved to 60.8 % compare to previous year, due to net income growth.


Financial Statements
Quidel's Equity $ 1,411 Millions QDEL's Balance sheet
Quidel's Income $ 19 Millions Quarterly QDEL's Income Statement
QDEL's Income by Division See QDEL's Income by Division

More Return On Equity Ratios
Biotechnology & Drugs Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
Roe Trends for overall market
QDEL's Roe Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Roe for QDEL's Competitors
Return On Equity for Quidel's Suppliers
Roe for QDEL's Customers

You may also want to know
QDEL's Roa QDEL's Inventory Turnover Ratio QDEL's Growth Rates QDEL's Dividend Statistics
QDEL's Annual Roe QDEL's Profitability Ratios QDEL's Asset Turnover Ratio QDEL's Dividend Growth
QDEL's Roi QDEL's Valuation Ratios QDEL's Financial Strength Ratios QDEL's Dividend Payout Ratio



Companies with similar Return On Equity at Jun 30 2021, within Healthcare Sector ROE
Halozyme Therapeutics Inc   190.72 %
Vyne Therapeutics Inc   138.73 %
Agios Pharmaceuticals Inc   129.96 %
Idexx Laboratories Inc  115.33 %
Molecular Templates Inc   107.63 %
Hanger inc   107.52 %
Tenet Healthcare Corp  100.88 %
Eli Lilly And Company  98.77 %
Ovid Therapeutics Inc   91.02 %
Retractable Technologies Inc  89.38 %
Moderna Inc   88.13 %
Vaso Corporation  80.89 %
Integrated Biopharma Inc  80.87 %
Alpha Pro Tech Ltd  79.65 %
Fulgent Genetics Inc   79.61 %
Uniqure N v   77.18 %
Integrity Applications Inc   71.81 %
Quidel Corporation  70.79 %
Davita Inc   70.43 %
Chemomab Therapeutics Ltd   69.93 %
Intersect Ent Inc   69.23 %
Semler Scientific inc   68.78 %
Manhattan Scientifics Inc   67.38 %
Co diagnostics Inc   65.33 %
Amgen Inc   60.57 %
Innoviva inc   60.40 %
Biomx Inc   59.71 %
Hologic Inc  59.58 %
The Cooper Companies Inc   59.14 %
Antares Pharma Inc   58.38 %



Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

LSBK's Profile

Stock Price

LSBK's Financials

Business Description

Fundamentals

Charts & Quotes

LSBK's News

Suppliers

LSBK's Competitors

Customers & Markets

Economic Indicators

LSBK's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071